Find past AATB Webinar and Conference presentations here. Registration provides one year of access to program recordings for one individual.
Allograft Skin in Burn and Reconstructive ProceduresIncludes Credits
In this session, a plastic surgeon who utilizes allograft skin in reconstructive procedures will present experiences and clinical cases which required allograft tissue.
A Practical Solution to Dealing with SepsisIncludes Credits
Overtime we have seen the number of acceptable donors decrease due to the increase in “sepsis” in a donor medical chart. An examination of our screening process revealed that the way we asked questions, how we reviewed charts and changes that hospitals made when evaluating a patient for possible sepsis have been responsible for some of the decline in the numbers of acceptable donors. In the past a potential donor could be found unsuitable because the donor was reported to be septic or possibly septic or the COD was reported to be sepsis or probable sepsis at initial screening. Sometimes sepsis showed up in a physician note or a review of specific laboratory data which led us to believe that the patient was possibly septic. The challenge was to develop new screening processes to help identify those donors who may not actually be septic while at the same time ensuring that we work within the FDA and AATB regulations. Other organizations, like ourselves, have developed new processes for screening. Though the processes differ in their design and degree of simplicity their goal is the same which is to be able to identify with some degree of accuracy those donors who may not be septic at the time of death. Examples include changing how questions are asked at initial screening, using an algorithm when reviewing a medical chart and even eliminating the need for Call Center personnel to review laboratory data. Today we will go over some of the changes we made, review our algorithm and discuss the advantages and disadvantages to screening this way.
Best Practices For Reducing Bioburden On Skin, Cardiac, And Musculoskeletal CulturesIncludes Credits
This presentation will highlight past culture rates for Gift of Life Michigan, LifeShare Carolinas, and the Center for Organ Recovery and Education. It will show that there were opportunities for improvement, what those improvements were, and the current statistics of culture rates within these organizations.
Birth Tissue Programs: A to ZIncludes Credits
The donation and acquisition of birth tissues present a number of technical hurdles to an OTPO that already recovers cadaveric tissue for transplantation. Birth Tissue A – Z will provide an overview of birth tissue program considerations and challenges. Focusing on the essential building blocks of a successful birth tissue program, we will review aspects of the birth tissue program that differ from traditional cadaveric tissue programs. The role of physicians and hospital staff will be discussed and we will provide insight surrounding the structure and typical challenges that an OTPO can encounter when implementing a birth tissue recovery program.
Bone Quality Considerations In Structural Allograft BankingIncludes Credits
In this session, from an engineer’s perspective, Prof. Willett will define bone quality and how it relates to the mechanical performance of cortical bone allograft. He will discuss the variability in and degradation of bone quality, particularly those independent of clinical bone mineral density measures, resulting from donor characteristics and disease states, processing, sterilization and implantation. Specific attention will be paid to the effects of gamma irradiation sterilization, recent progress in protecting the mechanical performance of cortical bone while still using conventional gamma irradiation sterilization, and opportunities and challenges for bone quality assessment in tissue banking.
Building And Maintaining A Healthy Tissue Recovery ProgramIncludes Credits
This session recorded session was presented as a part of the 2020 Virtual QDEW .
Clinical Applications and Material Options for Dental RegenerationIncludes Credits
This program will review the chemical and physical properties of various regenerative materials to assist clinicians in selecting the best materials to meet the clinical need of the patient. A comprehensive review of the many types of tissue-based products and their clinical applications will be presented in case format to provide a working knowledge of the most optimal bone graft material or membrane for the defect to achieve an aesthetic and predictable outcome for the patient.
Comprehensive Assessment Of Cryogenic Storage Risk And Quality ManagementIncludes Credits
Recent publicized events of cryogenic storage tank failures have created nationwide concern among infertility patients and patients storing embryos and gametes for future use. To assure patient confidence, quality management (QM) plans applied by in vitro fertilization (IVF) laboratories need to include a more comprehensive focus on the cryostorage of reproductive specimens. The purpose of this review is to provide best practice guidelines for the cryogenic storage of sperm, oocytes, embryos, and other reproductive tissues (e.g., testicular and ovarian tissue, cord blood cells, and stem cells) and recommend a strategy of thorough and appropriate quality and risk management procedures aimed to alleviate or minimize the consequences from catastrophic events.
Conducting the DRAI with a Grieving Family: Do Your Coordinators Understand Grief Concepts?Includes Credits
In this session, we will review basic concepts of grief and trauma with approaches to supporting families during such difficult times.
Creating Mutually Beneficial Collaborations with Out-of-Hospital PartnersIncludes Credits
Engaging out-of-hospital partners fosters a culture of donation throughout communities while providing mutually beneficial results. Learn more about working with law enforcement, hospice, coroners/medical examiner partners to increase donation opportunities and public outreach efforts.
Crossing Borders And Building Bridges: A Look At International Collaboration For Tissue Recovery TrainingIncludes Credits
This presentation will explain the collaboration process and system established for international tissue recovery training, its effectiveness and lessons learned. In 2013, the Ontario Ministry of Health and Long-Term Care wanted an integrated and effective tissue donation, banking, and transplant system for Ontario, and in 2017 tissue recovery was consolidated under Trillium Gift of Life Network (TGLN). The leadership team at TGLN had to develop a process to train all their recovery staff, this proved difficult due to very low donor numbers. TGLN decided that outsourcing training to an American OPO with higher donor numbers would be the most practical option for training and to learn best practices. LifeGift learned of the training opportunity and was selected as the OPO to train the TGLN recovery staff.
Current Geographically Relevant Communicable DiseasesIncludes Credits
This presentation will review current infectious diseases, epidemics and geographically relevant communicable diseases.
Diagnosing Cardiac Disease and Abnormality After ValvectomyIncludes Credits
This presentation will review practices, challenges and case studies surrounding post valve donation pathological examination.
Do We Believe in That? Religious Attitudes Towards Anatomical Gift DonationIncludes Credits
This presentation will strive to examine current official statements by various religious bodies and/or religious leaders regarding anatomical gift donation and discuss the disparity between corporately held beliefs and personal ones. In addition, this presentation will examine the challenges associated with interfacing with various religious bodies, such as language and symbolism and offer some suggestions moving forward.
Drug Related Deaths & EligibilityIncludes Credits
Through this session, we will review key considerations in determining donor eligibility in death involving prescription and illicit drugs. In addition to the concern for RCDADs, we will evaluate implications on tissue quality and viability as a result of chronic and acute drug involvement and toxicity.
Engaging Interdepartmental Cooperation With The Donor Family Services TeamIncludes Credits
Presentations often focus on the accomplishments of a single department, but what about the amazing work that is being done between departments within an organization or even between organizations? This presentation seeks to offer examples of cooperation between various departments/agencies by focusing on Family Services departments in three different organizations: Carolina Donor Services, Lions Eye Institute for Transplantation and Research and New England Donor Services. The objective of this presentation is to help participants identify opportunities for interdepartmental/interagency cooperation and encourage dialog both within and between organizations.
FDA Inspections: What to Expect, How to Prepare, and an Audit of Recent FindingsIncludes Credits
This presentation given by FDA ORA and CBER staff will provide information on what you can expect to occur during FDA inspections and how to prepare your staff and facility to be ready for FDA inspections. It will also include discussion of common observations (findings) and resulting compliance actions from FDA inspections conducted in the past couple of years.
How Non-Transplantable Tissue Is Used: Tragedy to TriumphIncludes Credits
In this session, we will review how one cardiac and vascular tissue establishment uses allografts unsuitable for transplant to train surgeons.
Human Cells, Tissues, and Cellular or Tissue-Based Products (HCT/Ps): Regulatory and Guidance Overview UpdateIncludes Credits
This presentation will provide an update on applicable FDA regulations and guidance documents for HCT/Ps, including updates on the related Agency activities.
Increasing Opportunities For Communication Between Donor Families And RecipientsIncludes Credits
This engaging presentation will enlighten attendees on the true value of a donor family & recipient connection. We will explain the obstacles in place that prohibit these connections among tissue donor families and recipients. We will further describe the need to eliminate these boundaries in order to best serve our key donation stakeholders. We will review a current working donor family/recipient correspondence model. Audience members can expect to leave this presentation feeling open minded & motivated to drive a change!
Individual Annual Subscription
Take advantage of the AATB Annual Subscription providing individual access to the entire year of educational programming With the Webinar Subscription Program, you can now have year-round access to subject matter experts and industry-leading education delivered right to your desk, conference room or smart phone. Start Learning More Throughout the Year. The Webinar Subscription Program gives you and your entire company access to more than 40 60-minute webinars a year and addresses key areas such as FDA inspections, surgical application, marketing trends and regulatory pathways. This content has been developed to support the diverse roles and experiences levels of this tissue community. What's Included in the Subscription Access to 40+ live presentation Recorded, on-demand access to each program Educational credits including CTBS, CEBT, RN and more!
Interdepartmental Collaboration: Reducing Division Throughout Your DivisionsIncludes Credits
In this session, we will review ideas and concepts surrounding breaking down silos in modern tissue banking and OPO organizational structure.
Just Culture: Thinking Differently About Human ErrorIncludes Credits
Are you interested in creating a learning environment with a quality mindset? In this session, we learn how to apply human factors and systems safety concepts in order to understand the true hazards in your organization. This session will shift one’s perspective from just looking at the error or event, to instead looking more critically at the system design and the influences driving employees’ behavioral choices.
Knee Joint Preservation: Osteochondral Allografts in 2019Includes Credits
In this presentation, orthopedic surgeon Dr. John Grant will review his experiences in utilizing allografts in joint reconstruction and restoration procedures.
Machine Learning And Prioritizing Incoming Tissue PotentialIncludes Credits
At the end of 2018, New England Donor Services (NEDS) renewed its focus on two areas: 1) increasing the total recoverable tissues amongst its referred tissue donor potential and 2) reducing the frequency of cases ruled out for tissue donation just before recovery could take place. By utilizing machine learning, a model algorithm was built to prioritize incoming tissue potential referrals in consideration of these two areas. Machine learning, the model algorithm, and its implementation into NEDS' Tissue Operations will be discussed and explored.
Medical Examiner/Coroner Cases: Cause & Manner of DeathIncludes Credits
This webinar will explore and elaborate upon the differences in cause and manner of death as determined on cases under the jurisdiction of a medical examiner, coroner or forensic pathologist. Through this lecture participants should gain a more comprehensive understanding in the medicolegal death investigation process, understand of the differences between cause of death, manner of death and their separation from the justice/prosecution of criminal cases.
NADO Storage and DistributionIncludes Credits
This webinar will review some requirements for storage of non-transplant tissues, depict some storage methods and arrangements of different accredited NADOs, and provide examples of non-transplant tissue distribution and research endeavors.
NAT Platform ChangesIncludes Credits
VRL is the first organ/tissue/eye donor screening laboratory to implement the Procleix Panther System (Grifols) for Nucleic Acid Testing (NAT), as FDA approval for use in the United States was recently announced. This presentation will focus on (i) platform changes (ii) NAT assay changes and (iii) the ability to test for several emerging infectious diseases. We will share our testing observations post-implementation.